First Manhattan CO Novartis Ag Transaction History

First Manhattan CO

  • $31.9 Billion
  • Q3 2024

A detailed history of First Manhattan CO transactions in Novartis Ag stock. As of the latest transaction made, First Manhattan CO holds 46,441 shares of NVS stock, worth $4.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
46,441
Previous 48,032 3.31%
Holding current value
$4.82 Million
Previous $5.11 Million 4.46%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $168,852 - $192,335
-1,591 Reduced 3.31%
46,441 $5.34 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $88,959 - $103,182
-961 Reduced 1.96%
48,032 $5.11 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $180,917 - $205,984
-1,899 Reduced 3.73%
48,993 $4.74 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $54,254 - $59,705
-588 Reduced 1.14%
50,892 $5.14 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $71,331 - $79,162
-753 Reduced 1.44%
51,480 $5.24 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $13.6 Million - $15.4 Million
-146,649 Reduced 73.74%
52,233 $5.27 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $251,294 - $291,423
-3,140 Reduced 1.55%
198,882 $18.3 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $69,657 - $85,303
922 Added 0.46%
202,022 $18.3 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $151,756 - $177,486
-2,034 Reduced 1.0%
201,100 $15.3 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $28,262 - $32,906
351 Added 0.17%
203,134 $17.2 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $7.59 Million - $8.59 Million
-94,754 Reduced 31.85%
202,783 $17.8 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $139,475 - $154,227
-1,750 Reduced 0.58%
297,537 $26 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $49,231 - $57,274
-602 Reduced 0.2%
299,287 $24.5 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $19,775 - $21,842
-232 Reduced 0.08%
299,889 $27.4 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $4,175 - $4,923
-50 Reduced 0.02%
300,121 $25.7 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $17.5 Million - $21.2 Million
224,598 Added 297.19%
300,171 $28.3 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $5,914 - $6,552
-72 Reduced 0.1%
75,573 $6.57 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $495,939 - $558,260
-6,128 Reduced 7.49%
75,645 $6.61 Million
Q1 2020

May 06, 2020
BUY
$70.67 - $99.01 $83,249 - $116,633
1,178 Added 1.46%
81,773 $6.74 Million
Q4 2019

Feb 13, 2020
SELL
$84.35 - $95.37 $215,345 - $243,479
-2,553 Reduced 3.07%
80,595 $7.63 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $35,499 - $39,117
415 Added 0.5%
83,148 $7.23 Million
Q2 2019

Aug 16, 2019
BUY
$75.4 - $92.8 $192,873 - $237,382
2,558 Added 3.19%
82,733 $7.55 Million
Q1 2019

Apr 12, 2019
BUY
$75.32 - $86.15 $849,835 - $972,030
11,283 Added 16.38%
80,175 $7.71 Million
Q4 2018

Jan 30, 2019
BUY
$73.66 - $82.02 $106,807 - $118,929
1,450 Added 2.15%
68,892 $5.91 Million
Q3 2018

Oct 15, 2018
SELL
$66.94 - $77.43 $108,041 - $124,972
-1,614 Reduced 2.34%
67,442 $5.81 Million
Q2 2018

Aug 01, 2018
SELL
$64.91 - $73.36 $144,424 - $163,226
-2,225 Reduced 3.12%
69,056 $5.22 Million
Q1 2018

Apr 20, 2018
SELL
$70.39 - $84.15 $140 - $168
-2 Reduced -0.0%
71,281 $5.76 Million
Q4 2017

Jan 22, 2018
SELL
$72.33 - $77.64 $1,157 - $1,242
-16 Reduced 0.02%
71,283 $5.98 Million
Q3 2017

Oct 25, 2017
BUY
$74.14 - $77.27 $5.29 Million - $5.51 Million
71,299
71,299 $6.12 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email